Article

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults

2023-10-02

Abstract excerpt

<h4>LONG ABSTRACT</h4> <h4>Background</h4> Infectious disease surveillance systems, which largely rely on diagnosed cases, underestimate the true incidence of SARS-CoV-2 infection, due to under-ascertainment and underreporting. We used repeat serologic testing to measure N-protein seroconversion in a well-characterized cohort of U.S. adults with no serologic evidence of SARS-CoV-2 infection to estimate the inciden...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3959eb6d-3280-5e63-b141-cd3743ea44ac
DOI: 10.1101/2023.09.29.23296142

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsDOI 10.1101/2023.09.29.23296142Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic reviewSemantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modeling studySemantic proximity Read

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysisSemantic proximity Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort StudySemantic proximity Read

Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, JapanSemantic proximity Read

Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infectionSemantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity Read

Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Semantic proximity Read